The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Drugs-Global Market Insights and Sales Trends 2024
Synopsis
An animal drug (also veterinary drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.
The global Animal Drugs market size is expected to reach US$ 33280 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Drugs in various end use industries. The expanding demands from the Livestock and Companion, are propelling Animal Drugs market. Anti-infective, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-inflammatory segment is estimated at % CAGR for the next seven-year period.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Drugs covered in this report include Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco, Bayer Animal Health, Ceva Animal Health, Virbac, Dechra and Phibro, etc.
The global Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco
Bayer Animal Health
Ceva Animal Health
Virbac
Dechra
Phibro
Vetoquinol
Ouro Fino Saude
Global Animal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Drugs market, Segment by Type:
Anti-infective
Anti-inflammatory
Parasiticides
Other
Global Animal Drugs market, by Application
Livestock
Companion
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An animal drug (also veterinary drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.
The global Animal Drugs market size is expected to reach US$ 33280 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Drugs in various end use industries. The expanding demands from the Livestock and Companion, are propelling Animal Drugs market. Anti-infective, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-inflammatory segment is estimated at % CAGR for the next seven-year period.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Drugs covered in this report include Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco, Bayer Animal Health, Ceva Animal Health, Virbac, Dechra and Phibro, etc.
The global Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco
Bayer Animal Health
Ceva Animal Health
Virbac
Dechra
Phibro
Vetoquinol
Ouro Fino Saude
Global Animal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Drugs market, Segment by Type:
Anti-infective
Anti-inflammatory
Parasiticides
Other
Global Animal Drugs market, by Application
Livestock
Companion
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Animal Drugs
1.1 Animal Drugs Market Overview
1.1.1 Animal Drugs Product Scope
1.1.2 Animal Drugs Market Status and Outlook
1.2 Global Animal Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Animal Drugs Market Size by Region (2018-2029)
1.4 Global Animal Drugs Historic Market Size by Region (2018-2023)
1.5 Global Animal Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Animal Drugs Market Size (2018-2029)
1.6.1 North America Animal Drugs Market Size (2018-2029)
1.6.2 Europe Animal Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Animal Drugs Market Size (2018-2029)
1.6.4 Latin America Animal Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Animal Drugs Market Size (2018-2029)
2 Animal Drugs Market by Type
2.1 Introduction
2.1.1 Anti-infective
2.1.2 Anti-inflammatory
2.1.3 Parasiticides
2.1.4 Other
2.2 Global Animal Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Animal Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Animal Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Animal Drugs Revenue Breakdown by Type (2018-2029)
3 Animal Drugs Market Overview by Application
3.1 Introduction
3.1.1 Livestock
3.1.2 Companion
3.2 Global Animal Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Animal Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Animal Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Animal Drugs Revenue Breakdown by Application (2018-2029)
4 Animal Drugs Competition Analysis by Players
4.1 Global Animal Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Drugs as of 2022)
4.3 Date of Key Players Enter into Animal Drugs Market
4.4 Global Top Players Animal Drugs Headquarters and Area Served
4.5 Key Players Animal Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Animal Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zoetis
5.1.1 Zoetis Profile
5.1.2 Zoetis Main Business
5.1.3 Zoetis Animal Drugs Products, Services and Solutions
5.1.4 Zoetis Animal Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Zoetis Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Animal Drugs Products, Services and Solutions
5.2.4 Boehringer Ingelheim Animal Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Merck Animal Health
5.3.1 Merck Animal Health Profile
5.3.2 Merck Animal Health Main Business
5.3.3 Merck Animal Health Animal Drugs Products, Services and Solutions
5.3.4 Merck Animal Health Animal Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Elanco Recent Developments
5.4 Elanco
5.4.1 Elanco Profile
5.4.2 Elanco Main Business
5.4.3 Elanco Animal Drugs Products, Services and Solutions
5.4.4 Elanco Animal Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Elanco Recent Developments
5.5 Bayer Animal Health
5.5.1 Bayer Animal Health Profile
5.5.2 Bayer Animal Health Main Business
5.5.3 Bayer Animal Health Animal Drugs Products, Services and Solutions
5.5.4 Bayer Animal Health Animal Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Animal Health Recent Developments
5.6 Ceva Animal Health
5.6.1 Ceva Animal Health Profile
5.6.2 Ceva Animal Health Main Business
5.6.3 Ceva Animal Health Animal Drugs Products, Services and Solutions
5.6.4 Ceva Animal Health Animal Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Ceva Animal Health Recent Developments
5.7 Virbac
5.7.1 Virbac Profile
5.7.2 Virbac Main Business
5.7.3 Virbac Animal Drugs Products, Services and Solutions
5.7.4 Virbac Animal Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Virbac Recent Developments
5.8 Dechra
5.8.1 Dechra Profile
5.8.2 Dechra Main Business
5.8.3 Dechra Animal Drugs Products, Services and Solutions
5.8.4 Dechra Animal Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Dechra Recent Developments
5.9 Phibro
5.9.1 Phibro Profile
5.9.2 Phibro Main Business
5.9.3 Phibro Animal Drugs Products, Services and Solutions
5.9.4 Phibro Animal Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Phibro Recent Developments
5.10 Vetoquinol
5.10.1 Vetoquinol Profile
5.10.2 Vetoquinol Main Business
5.10.3 Vetoquinol Animal Drugs Products, Services and Solutions
5.10.4 Vetoquinol Animal Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Vetoquinol Recent Developments
5.11 Ouro Fino Saude
5.11.1 Ouro Fino Saude Profile
5.11.2 Ouro Fino Saude Main Business
5.11.3 Ouro Fino Saude Animal Drugs Products, Services and Solutions
5.11.4 Ouro Fino Saude Animal Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Ouro Fino Saude Recent Developments
6 North America
6.1 North America Animal Drugs Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Animal Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animal Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animal Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animal Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animal Drugs Market Dynamics
11.1 Animal Drugs Industry Trends
11.2 Animal Drugs Market Drivers
11.3 Animal Drugs Market Challenges
11.4 Animal Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
